AABB or the American Association of Blood Bank is an association established for governing and setting standards for blood banks for 50 states in the United of America. Later, it becomes to be an international association that brings together scholars who are expert on medical science, all examination techniques in blood bank, and blood disease treatment, and sets the standards for quality inspection and accreditation.
In addition, there are other international organizations that play a role in blood service- -including World Health Organization (WHO), International Federation of Red Cross and Red Crescent Societies – IFRC/RC), International Society of Blood Transfusion – ISBT) , International Federation of Blood Donor Organizations – IFBDO/ FIODS), Council of Europe – COE, and International Plasma Fractionation Association – IPFA).
For the blood banks in Thailand, the National Blood Center, Thai Red Cross Society, has collaborated with Ministry of Public Health and the University Bureau as the main organization for building cooperation and determining the National Blood Policy to be the master plan and guideline. For the blood service in 1989. The master plan and guideline are updated in 1995 and 2010, and become to be the version used today. Many standard systems are set to cover a wide variety of tasks and to ensure that they can be performed to achieve the goals and to meet the guidelines of the World Health Organization. It has been certified according to ISO 9001 in 2000, and ISO 15189 and ISO 15190 for medical laboratory in 2014, and recently GMP certification for the manufacturing sector in 2017.
Due to an increase in stem cell operations and development in Thailand today, National Blood Center – which is responsible for and is part of this development nationally–has therefore planned and implemented the system in accordance with World Marrow Donor Association (WMDA) standard, which is the international Standards for Unrelated Hematopoietic Stem Cell Donor Registries, for providing allogeneic stem cell donation service, with the schedule for completion in 2020. Moreover, National Blood Center still commits to raise the standards to be strengthen and to cover all departments and responsible missions.
For SCL laboratory, blood stem cell separation has been performed in accordance with the requirements of the National Blood Center, the Thai Red Cross Society in order to conform with the World Health Organization guidelines strictly. The quality control system of production standard (Good Manufacturing Practice: GMP) , the inspection of product quality (Qualification & Safety Control) for use of cell therapy will be based on the requirements of Advanced Therapy Medicinal Products (ATMPs), as well as characterization of the cell product before use.
In addition, for mesenchymal stem cell (MSCs), there is a preliminary agreement for product verification by The International Society for Cellular Therapy (ISCT). It can be seen that all of these requirements are the standard of validation for obtaining the good quality and safe hematopoietic stem cells according to the standard of National Blood Center, the Thai Red Cross Society, which meet the goals and guidelines of World Health Organization.